The Theranostics Trial Alliance Sweden (TTA Sweden for short) is a national partnership for image-guided diagnostics and therapies with targeting radiopharmaceuticals. This Vinnova-funded project aims to promote the development, testing and clinical implementation of new antibody-based molecular therapeutic strategies within Precision Oncology in a streamlined manner and in the shortest time.
The project is led by the Theranostics Trial Center at Karolinska University Hospital. Other aprtners in the project are Karolinska Institutet, Affibody and Akiram Therapeutics. IHE is leading work package five which focuses on the development of health economic models to evaluate the cost-effectiveness of theranostic interventions.